海洋生物活性化合物:改善COPD骨肌肉功能障碍的有希望的策略
Meiling Jiang1, Peijun Li2, Xiaoyu Han1
1Department of Sports Rehabilitation, Shanghai University of Sport, Shanghai 200438, China.
Marine drugs
|April 25, 2025
概括
海洋化合物在慢性阻塞性肺病 (COPD) 中对抗骨肌肉功能障碍方面表现有前途. 这些天然物质为这种严重的COPD并发症提供了潜在的新疗法,改善了患者的治疗结果.
科学领域:
- 海洋生物学 海洋生物学
- 肺部病理学 肺部病理学
- 生物化学 生化学
背景情况:
- 骨肌功能障碍是慢性阻塞性肺病 (COPD) 的严重并发症,预后和死亡率恶化.
- 这种功能障碍导致运动能力下降和COPD恶化更频繁.
研究的目的:
- 审查与COPD相关的骨肌肉功能障碍有治疗潜力的海洋生物活性化合物.
- 探索这些化合物的抗炎和抗氧化特性.
主要方法:
- 关于海洋衍生生物活性化合物的文献综述.
- 对多糖,脂质,多,和胡卜素的研究进行分析.
- 评估它们对骨肌肉健康和缩的影响.
主要成果:
- 海洋化合物,包括多糖,脂质,多,和胡卜素,表现出显著的抗炎和抗氧化活性.
- 这些化合物已在临床前和临床研究中证明在促进骨肌肉健康和减轻肌肉缩方面具有有效性.
- 特定的海洋衍生化合物显示出在COPD骨肌肉功能障碍中直接治疗应用的潜力.
结论:
- 来自海洋的生物活性化合物代表了针对COPD骨肌肉功能障碍的新型治疗策略的有希望的途径.
- 这些天然产品有潜力预防和治疗肌肉衰竭,并改善COPD患者的运动能力.
- 对这些化合物的进一步研究可以显著扩大治疗方案,以管理COPD并发症.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
122
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
122
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Skeletal Muscle Relaxants: Therapeutic Uses
439
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
439
Skeletal Muscle Relaxants: Adverse Effects
309
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
309
Direct-Acting Cholinergic Agonists: Therapeutic Uses
615
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
615


